Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2496
    -0.0015 (-0.12%)
     
  • Bitcoin GBP

    51,095.25
    -611.87 (-1.18%)
     
  • CMC Crypto 200

    1,330.96
    -65.58 (-4.70%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.65
    +0.08 (+0.10%)
     
  • GOLD FUTURES

    2,350.90
    +8.40 (+0.36%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Xilinx Earnings Beat, Revenue Misses In Q3

Xilinx Earnings Beat, Revenue Misses In Q3
Xilinx Earnings Beat, Revenue Misses In Q3

Investing.com - Xilinx (NASDAQ:XLNX) announced third quarter earnings that beat analysts' expectations on Tuesday and revenue that fell short of forecasts.

The company reported earnings per share of $0.68 on revenue of $723.5M. Analysts polled by Investing.com forecast EPS of $0.6 on revenue of $731.35M. That was in comparison to EPS of $0.93 on revenue of $800.06M in the same quarter a year before. Xilinx had announced EPS of $0.89 on revenue of $833M in the previous quarter.

Analysts are expecting EPS of $0.81 and revenue of $825.11M in the next quarter.

Xilinx share's are up 0.86% for the year to date , still down 30.36% from its 52 week high of $141.60 set on April 24, 2019.

Xilinx follows other major Technology sector earnings this month

On January 21, IBM reported fourth quarter EPS of $4.71 on revenue of $21.78B, was in comparison with a forecasts for EPS of $4.69 on revenue of $21.64B.

ADVERTISEMENT

Intel earnings beat analysts' expectations on Thursday, with fourth quarter EPS of $1.52 on revenue of $20.21B. Investing.com analysts forecast EPS of $1.25 on revenue of $19.23B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

Exclusive: OxyContin maker Purdue is 'Pharma Co X' in U.S. opioid kickback probe - sources

Starbucks expects hit from coronavirus after closing half of China stores

Exclusive: Do or die - Nissan takes the axe to the house Ghosn built